Our experts have written, co-written, and provided insights into hundreds of publications.
Soini E, et al. Health-Related Quality of Life (HRQoL) based on preferences from 14 countries in Primary Health Care Setting (PHCS). Value Health 2016;19:A472.
Väätäinen S, Cederberg H, Roine R, Keinänen-Kiukaanniemi S, Saramies J, Uusitalo H, Tuomilehto J, Martikainen J. Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC). PLoS One 2016;11(2):e0147898.
Heiskanen J, Tolppanen A-M, Roine RP, Hartikainen J, Hippeläinen M, Miettinen H, Martikainen J. Comparison of EQ-5D and 15D instruments for assessing the health-related quality of life in cardiac surgery patients. Eur Heart J Qual Care Clin Outcomes 2016;2(3):193-200.
Koivisto AM, Hallikainen I, Välimäki T, Hongisto K, Hiltunen A, Karppi P, Sivenius J, Soininen H, Martikainen J. Early psychosocial intervention does not delay institutionalization in persons with mild Alzheimer disease and has impact on neither disease progression nor caregivers’ well-being. Int J Geriatr Psychiatry 2016;31(3):273-83.
Välimäki TH, Martikainen JA, Hongisto K, Väätäinen S, et al. Impact of Alzheimer’s disease on the family caregiver’s long-term quality of life. Qual Life Res 2016;25(3):687-97.
Asklöf T, Martikainen J, et al. Paid expenditures and productivity costs associated with permanent disability pensions in patients with spinal disorders: Nationwide Finnish Register-based Study, 1990-2010. Eur Spine J 2016;25(1):275-81.
Soini E, et al. Watch out for Berkson’s Bias (BB)! Setting Health-Related Quality of Life (HRQoL) treatment targets with Matching-Adjusted Indirect Comparison (MAIC) in order to predict Matched General Population Control (MGPC) targets, assess Potential to Benefit (PtB) and reveal Unmet Medical Need (UMN). Value Health 2016;19(7):A392.
Martikainen J, Viramo P. Muistisairaudet ja terveystalous. In: Muistisairaudet. 2. uudistettu painos, p. 44–55. Eds. Erkinjuntti T, Remes A, Rinne J, Soininen H. Duodecim: Helsinki, 2015.
Soini E. Terveystalousanalyysien hyödyntäminen ja käyttö asiakasviestinnässä. Lääketietokeskus: Terveystalousanalyysit ja tilastolliset päättelyt tutuiksi – miten hyödynnän malleja ja tuloksia omassa työssäni. Helsinki: training. Sep 16, 2015.
Martikainen JA, et al. Longterm Work Productivity Costs Due to Absenteeism and Permanent Work Disability in Patients with Early Rheumatoid Arthritis: A Nationwide Register Study of 7831 Patients. J Rheumatol 2016;43:2101-5.
Aarnio E, Martikainen J, et al. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter? Circ Cardiovascular Qual Outcomes 2016;9(6):704-13.
Hallinen T, Soini E, et al. Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients. SpringerPlus 2016;5:1354.
Heiskanen J, Martikainen J, et al. The coverage of elective revascularisation procedure codes in the National Finnish Hospital Discharge Register. Ann Med 2016;48(7):552-8.
Soini E, Hautala A, Poikonen E, Becker U, Kyttälä M, Martikainen J. Cost-Effectiveness of First-Line Chronic Lymphocytic Leukemia Treatments When Full-Dose Fludarabine Is Unsuitable. Clin Ther 2016;38(4):889-904.
Väätäinen S, Soini E, et al. Cost-effectiveness of ustekinumab in the treatment of psoriasis in Finland. Value Health 2015;18:A670.
Mankinen P, Soini E, Laine J, Linna M, Åhman H, Martikainen J. Health economic impact of 13-valent pneumococcal conjugate vaccine in Finnish home care customers >50 years with underlying chronic medical conditions. Value Health 2015;18:A579.
Aarnio E, Korhonen MJ, Huupponen R, Martikainen J. Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register. Atherosclerosis 2015;239(1):240-7.
Soini E, et al. Cost-effectiveness of First-line disease-modifying treatments for relapsing-remitting MS. ECTRIMS 2015 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis. P660.
Rantalaiho V, Leirisalo-Repo M, Kautiainen H, Mankinen P, Martikainen J, et al. Vitality, Presenteeism, and Their Determinants in Patients with Early Rheumatoid Arthritis Treated with a 6-Month Induction Infliximab Therapy Added on a Triple Combination Therapy. Arthritis & Rheumatology 2015; 67 (suppl 10).
Soini E, et al. Cost-effectiveness of first-line disease-modifying therapies (DMTs) for relapsing-remitting MS (RRMS). Value Health 2015;18(7):A756.
Sopina E, Martikainen J, et al. Validation of a Markov model for economic evaluation of screening and preventive interventions in Alzheimer’s disease in Denmark. Value Health 2015;18:A695.
Laskentamalli apuna tilojen hahmottamisessa. Haastateltu: Soini E. Terveys ja talous 2014;77(2):44.
Heinonen J, Koskela T, Soini E, et al. Primary-care-based episodes of care and their costs in a three-month follow-up in Finland. Scand J Prim Health Care 2015;33(4):283-90.
Törmälehto SM, Martikainen JA, Väätäinen ST, et al. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer’s Disease over a Three-Year Period. J Alzheimers Dis. 2015;48(4):1033-41.
Välimäki TH, Martikainen JA, Hallikainen IT, Väätäinen ST, et al. Depressed Spousal Caregivers Have Psychological Stress Unrelated to the Progression of Alzheimer Disease: A 3-Year Follow-Up Report. J Geriatr Psychiatry Neurology 2015;28(4):272-80.
Soini E, Hallinen T, et al. Cost-Utility of First-Line Actinic Keratosis Treatments in Finland. Adv Ther 2015;32(5):455-76.
Gilmartin JF, Väätäinen S, Törmälehto S, Bell JS, Lönnroos E, Salo L, Hallikainen I, Martikainen J, et al. Depressive symptoms are associated with analgesic use in people with Alzheimer’s disease. PLoS One 2015;10(2):e0117926.
Soini E, et al. Glycosylated haemoglobin (HbA1c) monitoring and lower HBA1c values can result to higher quality of life? Beta regression modelling. 15th Biennial SMDM European Meeting, Antwerpen. Program and abstracts 2014.
Heinonen J, Soini E, et al. Costs of episodes (COE): analysis based on ICPC-2 classification. 15th Biennial SMDM European Meeting, Antwerpen. Program and abstracts, 2014.
Asseburg, C. Det internationella Mount Hood-samarbetet. Tredje nationella hälsoekonomiska konferensen, Lund, Sweden, Mar 20-21, 2014.